Health Institution Exemption

2025 in MedTech: a year of innovation, global leadership and regulatory milestones

Posted by: , Posted on: - Categories: AI Airlock, Diagnostics, Health Institution Exemption, IMDRF, IVD, Med Tech Regulations, Medical Devices, Post-Market Surveillance, Pre-market statutory instrument, Uncategorized

Rob Reid, MHRA deputy director of innovation devices, at AI Airlock Connect, October 2025 As the end of 2025 rapidly approaches, I find myself searching out those articles and lists that reflect on key moments across the year. Whether it …

Innovative approaches to Med Tech regulatory reform

Posted by: , Posted on: - Categories: AI Airlock, designated standards, Health Institution Exemption, Med Tech Regulations, Medical Devices

Well, hello again.  Hasn’t time passed by so quickly since my last blog in September. At the MHRA, we have many exciting and pioneering initiatives underway. I was listening to a medical device podcast recently and the podcast host proclaimed …